Exelixis | Costo Del Venduto



Cost Of Sales Cambiamento Data
Acadia Pharmaceuticals USD 20.73M 342K 2025-06
Agios Pharmaceuticals USD 1.7M 617K 2025-06
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.47B 232M 2025-06
Bayer EUR 5.62B 98M 2025-03
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Cytokinetics 99.84M 99.38M 2025-03
Eisai JPY 42.6B 2B 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Exelixis USD 19.47M 298K 2025-07
Genmab DKK 42M 295M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Incyte USD 78.77M 10.96M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.82B 53M 2025-06
Moderna USD 119M 29M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Novartis USD 3.32B 95M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Sanofi EUR 2.27B 1.81B 2024-12
Takeda JPY 384.68B 2.6B 2025-06
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Xencor 10.71M 4.56M 2024-09


Exelixis Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.